Laboratorio Farmaceutico Erfo SpA (IT:ERFO) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Laboratorio Farmaceutico Erfo S.p.A., listed on Euronext Growth Milan, has acquired 4,000 shares as part of its ongoing buyback plan, representing 0.04% of its share capital. This latest purchase brings their total treasury shares to 5.44% of the share capital. The company continues to focus on expanding its business lines and enhancing its nutraceutical offerings.
For further insights into IT:ERFO stock, check out TipRanks’ Stock Analysis page.